These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 20227042)

  • 1. Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.
    He G; Yu GY; Temkin V; Ogata H; Kuntzen C; Sakurai T; Sieghart W; Peck-Radosavljevic M; Leffert HL; Karin M
    Cancer Cell; 2010 Mar; 17(3):286-97. PubMed ID: 20227042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response.
    Sunami Y; Ringelhan M; Kokai E; Lu M; O'Connor T; Lorentzen A; Weber A; Rodewald AK; Müllhaupt B; Terracciano L; Gul S; Wissel S; Leithäuser F; Krappmann D; Riedl P; Hartmann D; Schirmbeck R; Strnad P; Hüser N; Kleeff J; Friess H; Schmid RM; Geisler F; Wirth T; Heikenwalder M
    Hepatology; 2016 May; 63(5):1592-607. PubMed ID: 26892811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.
    Sakurai T; Maeda S; Chang L; Karin M
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10544-51. PubMed ID: 16807293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.
    Maeda S; Kamata H; Luo JL; Leffert H; Karin M
    Cell; 2005 Jul; 121(7):977-90. PubMed ID: 15989949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.
    Yau TO; Chan CF; Gee-San Lam S; Cheung OF; Ching YP; Jin DY; Sham MH; Ng IO
    J Pathol; 2009 Feb; 217(3):353-61. PubMed ID: 19090486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic functions of TNF-alpha determine distinct IKKbeta-dependent hepatocellular fates in response to LPS.
    Dajani R; Sanlioglu S; Zhang Y; Li Q; Monick MM; Lazartigues E; Eggleston T; Davisson RL; Hunninghake GW; Engelhardt JF
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G242-52. PubMed ID: 16935850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB and STAT3 - key players in liver inflammation and cancer.
    He G; Karin M
    Cell Res; 2011 Jan; 21(1):159-68. PubMed ID: 21187858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer.
    Jiang R; Xia Y; Li J; Deng L; Zhao L; Shi J; Wang X; Sun B
    Int J Cancer; 2010 Mar; 126(5):1263-74. PubMed ID: 19728335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted deletion of hepatocyte Ikkbeta confers growth advantages.
    Koch KS; Maeda S; He G; Karin M; Leffert HL
    Biochem Biophys Res Commun; 2009 Mar; 380(2):349-54. PubMed ID: 19171122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
    Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
    Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diclofenac inhibits tumor necrosis factor-α-induced nuclear factor-κB activation causing synergistic hepatocyte apoptosis.
    Fredriksson L; Herpers B; Benedetti G; Matadin Q; Puigvert JC; de Bont H; Dragovic S; Vermeulen NP; Commandeur JN; Danen E; de Graauw M; van de Water B
    Hepatology; 2011 Jun; 53(6):2027-41. PubMed ID: 21433042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin-6 expression.
    Maeda S; Hikiba Y; Sakamoto K; Nakagawa H; Hirata Y; Hayakawa Y; Yanai A; Ogura K; Karin M; Omata M
    Hepatology; 2009 Dec; 50(6):1851-60. PubMed ID: 19821485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation.
    Zhang W; Zhangyuan G; Wang F; Jin K; Shen H; Zhang L; Yuan X; Wang J; Zhang H; Yu W; Huang R; Xu X; Yin Y; Zhong G; Lin A; Sun B
    Immunity; 2021 Jun; 54(6):1168-1185.e8. PubMed ID: 34038747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes.
    Wullaert A; Heyninck K; Beyaert R
    Biochem Pharmacol; 2006 Oct; 72(9):1090-101. PubMed ID: 16934229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis.
    Bollrath J; Greten FR
    EMBO Rep; 2009 Dec; 10(12):1314-9. PubMed ID: 19893576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory tales of liver cancer.
    Hoffmann A; Xia Y; Verma IM
    Cancer Cell; 2007 Feb; 11(2):99-101. PubMed ID: 17292819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of indomethacin leads to poor prognoses through promoting the expression of PD-1 and PD-L2 via TRIF/NF-κB pathway and JAK/STAT3 pathway to inhibit TNF-α and IFN-γ in hepatocellular carcinoma.
    Xu P; Sun Z; Wang Y; Miao C
    Exp Cell Res; 2015 Sep; 337(1):53-60. PubMed ID: 26162855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic NF-kB-inducing kinase (NIK) suppresses mouse liver regeneration in acute and chronic liver diseases.
    Xiong Y; Torsoni AS; Wu F; Shen H; Liu Y; Zhong X; Canet MJ; Shah YM; Omary MB; Liu Y; Rui L
    Elife; 2018 Aug; 7():. PubMed ID: 30070632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.